Stéphanie P.
- Country
- France
- Department
- Oncology for pediatrics
Research Overview
- Randomized Phase II/III Study of Cabozantinib Maintenance Versus Best Supportive Care in Osteosarcoma Patients After First‑Line Chemotherapy (FOSTER‑CabOS)
- Phase 2 Multicentre Randomized Trial of Mifamurtide with Post-Operative Chemotherapy in High-Risk Osteosarcoma Patients
- Phase 3 Study of Busulfan, Melphalan, and Chemoimmunotherapy in High-Risk Neuroblastoma Patients with Insufficient Metastatic Response
Data & Insights
Has run more than one trial at 136 of 269 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating complex pediatric liver tumors, with particular focus on hepatoblastoma and hepatocellular carcinoma. Their expertise extends to managing various risk groups and therapeutic approaches for these conditions.
- Liver Cancer Treatment Protocols
- Risk-Stratified Treatment Approaches
- Pediatric Surgical Oncology
Musculoskeletal Oncology
The investigator focuses on treating high-risk osteosarcoma and rhabdomyosarcoma, particularly in young patients. Their work encompasses both localized and metastatic disease management, including innovative therapeutic combinations.
- Bone Cancer Therapeutics
- Soft Tissue Sarcoma Management
- Multimodal Treatment Strategies
Advanced Therapeutic Approaches
The investigator has expertise in treating neuroblastoma and rare tumors like small cell ovarian carcinoma. Their work involves peptide receptor radionuclide therapy and novel therapeutic combinations for refractory conditions.
- Immunotherapy Applications
- Targeted Radiation Treatments
- Combination Therapy Protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.